WARNING: Methadone should only be prescribed for pain by experienced clinicians! Indubitably, the most difficult opioid conversion challenge to prescribers and pharmacists is methadone. Methadone to Morphine (or equivalent) ≠ Morphine (or equivalent) to Methadone. Methadone conversion.
So true I’m 29 years old I’ve already had 2 back surgery’s and looking at another I have 2 herniated disc pinching my Sciatic nerve and 2 bulging disc in my upper back and kyphosis Because of all of this crap my pain dr is scared and has lowered my medication so much that I can barely function during the day I’m only 29 years old and have to live with my grandparents to help me in no way is that right!
attitude changed….Drs became fearful of the law, and patient care took a back seat.
Use of Oral Methadone for Chronic Pain. Opioid-naïve patients. Recommended starting dose range is 2.5 mg daily to 2.5 mg TID. For frail and/or older patients, the starting dose is 2.5 mg daily. Patients taking opioids. Determine the daily oral morphine equivalent dose of current opioids. Convert daily oral morphine.
None or 1 - 2 mg/hr.
0.2 mg (0.05 - 0.4 mg).
7 - 8 min Immediate.
Continue looking for other causes of sedation and respiratory depression. Titrate naloxone until patient is responsive or a total of 0.8 mg (20 ml of diluted solution) has been given.
4 - 6 hr 12 hr Liver 4 hr.
2 - 4 hr.
5 - 10 min.
30 - 60 min 20 min.
0.04 mg/ml (40 mcg/ml) dilution in syringe (mix 0.4 mg/1 ml of naloxone and 9 ml of normal saline in a syringe for IV administration).
0.25 - 1 mcg/Kg as needed 25 mcg/hr.
4 - 24 hr Liver 24 hr.
1 - 2 hr.
5 - 10 mg hydrocodone q 4 - 6 hr 60 min 2 hr.
These are general guidelines.
We provide an opioid conversion table (Appendix 1) for commonly used opioid preparations to help clinicians better understand the relationship between these agents and methadone. Conversion must take into consideration clinical issues that affect translation of equivalents to and.
These substances bind to the µ receptors for their euphorigenic, mood-altering, and dependence-producing properties. Positron emission tomography (PET) scan of µ receptors shows them to be located in the (1) thalamus (highest concentrations and involved in pain), (2) cerebral cortex (intermediate concentrations), (3) basal ganglia (intermediate concentrations and involved in movement and emotions), and (4) visual cortex (lowest concentrations). 2 PET scanning has also located µ receptors in the pons and medulla, but semiquantitative estimates are not available.
For those who may have used the Methadone Conversion Factor during that period, we advise discarding your original calculations and re-inputting your information in order to confirm their values. DISCLAIMER OF WARRANTY. THE CALCULATOR IS PROVIDED FREE OF CHARGE "AS IS" AND "AS AVAILABLE" AND IS.
DISCLAIMER OF WARRANTY. WITHOUT LIMITING THE FOREGOING, COMPANY, ITS AFFILIATED COMPANIES AND THE AUTHOR(S) OF THE CALCULATOR AND EACH OF THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, SUPPLIERS, AND PARTNERS, DO NOT WARRANT THAT: (A) THE CALCULATOR WILL BE SECURE, AVAILABLE AT ANY PARTICULAR TIME OR LOCATION, OR UNINTERRUPTED OR ERROR FREE; (B) ANY DEFECTS OR ERRORS IN THE CALCULATOR CAN OR WILL BE CORRECTED; OR THE RESULTS OF USING THE CALCULATOR WILL MEET YOUR REQUIREMENTS. THE CALCULATOR IS PROVIDED FREE OF CHARGE "AS IS" AND "AS AVAILABLE" AND IS WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, AND ANY WARRANTIES IMPLIED BY ANY COURSE OF PERFORMANCE OR USAGE OF TRADE, ALL OF WHICH ARE EXPRESSLY DISCLAIMED.
Data obtained from the use of the Calculator is not meant for direct clinical application.
Nonpharmacologic therapy and nonopioid pharmacologic therapy are preferred for chronic pain. Clinicians should consider opioid therapy only if expected benefits for both pain and function are anticipated to outweigh risks to the patient. If opioids are used, they should be combined with nonpharmacologic.
(Open Table in a new window). Table.
See the list below:
Stephen Kishner, MD, MHA Professor of Clinical Medicine, Physical Medicine and Rehabilitation Residency Program Director, Louisiana State University School of Medicine in New Orleans Stephen Kishner, MD, MHA is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine Disclosure: Nothing to disclose.
Conversion from oral or transdermal to parenteral route results in more rapid analgesic effects.